R.K.Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 20.86%
- Profit Growth -57.67%
- Ebitda -21.64%
- Net Worth 2.28%
- Total Assets 24.51%
About R.K.Medicare
R.K.Medicare Private Limited (RPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2006 and has a history of 18 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Pragati Singhal and Sanjay Singhal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2006PTC160772
-
Company No.
160772
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Mar 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does R.K.Medicare Private Limited offer?
R.K.Medicare Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Hair Care Products, Masala Powder, Green Cardamom Powder, Herbal Juice, Aloe Vera Juice, Amla Juice, Tea Powder, Green Tea Leaves Powder, Herbal Oil.
Who are the key members and board of directors at R.K.Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pragati Singhal
|
Director | 28-Mar-2006 | Current |
|
Sanjay Singhal
|
Director | 28-Mar-2006 | Current |
Financial Performance of R.K.Medicare.
R.K.Medicare Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 20.86% increase. The company also saw a substantial fall in profitability, with a 57.67% decrease in profit. The company's net worth moved up by a moderate rise of 2.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.K.Medicare?
In 2017, R.K.Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2017 | Others | ₹2.00 M | Open |
How Many Employees Work at R.K.Medicare?
Unlock and access historical data on people associated with R.K.Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.K.Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.K.Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
